Trientine hydrochloride

From WikiMD.org
Jump to navigation Jump to search

Trientine Hydrochloride

Trientine hydrochloride (pronunciation: try-EN-teen HY-droh-KLOR-ide) is a medication used primarily in the treatment of Wilson's disease, a rare inherited disorder that causes copper to accumulate in the body's organs.

Etymology

The name "trientine" is derived from the Greek word "tri" meaning three and "entine" referring to the three nitrogen atoms in the molecule. The term "hydrochloride" refers to the hydrochloric acid salt form of the drug.

Pharmacology

Trientine hydrochloride is a chelating agent that binds to copper and forms a stable complex, which is then excreted from the body. This reduces the amount of copper in the body and helps to alleviate the symptoms of Wilson's disease.

Usage

Trientine hydrochloride is used when treatment with D-penicillamine, the first-line treatment for Wilson's disease, is not possible or causes severe side effects. It may also be used in combination with other treatments for Wilson's disease.

Side Effects

Common side effects of trientine hydrochloride include nausea, vomiting, and diarrhea. Less common side effects can include anemia, lupus-like syndrome, and neurological symptoms.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski